Gut bacteria transplant trial aims to reboot cancer treatment
Disease control
Not yet recruiting
This study is testing whether a fecal microbiota transplant (FMT) can help a cancer immunotherapy drug work again for people with advanced non-small cell lung cancer. The treatment is for patients whose cancer has continued to grow despite previous immunotherapy. Researchers will…
Phase: PHASE2 • Sponsor: Se-Hoon Lee • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC